| Literature DB >> 21339948 |
Carine Le Ker1, Karina-Ethel Petit, Jean-François Biard, Joël Fleurence.
Abstract
In the search for bioactive natural products, our lab screens hydrophobic extracts from marine fungal strains. While hydrophilic active substances were recently identified from marine macro-organisms, there was a lack of reported metabolites in the marine fungi area. As such, we decided to develop a general procedure for screening of hydrophobic metabolites. The aim of this study was to compare different processes of fermentation and extraction, using six representative marine fungal strains, in order to define the optimized method for production. The parameters studied were (a) which polar solvent to select, (b) which fermentation method to choose between solid and liquid cultures, (c) which raw material, the mycelium or its medium, to extract and (d) which extraction process to apply. The biochemical analysis and biological evaluations of obtained extracts led to the conclusion that the culture of marine fungi by agar surface fermentation followed by the separate extraction of the mycelium and its medium by a cryo-crushing and an enzymatic digestion with agarase, respectively, was the best procedure when screening for hydrophilic bioactive metabolites. During this development, several bioactivities were detected, confirming the potential of hydrophilic crude extracts in the search for bioactive natural products.Entities:
Keywords: agar surface fermentation; bioactivity; extraction process; hydrophilic metabolites; marine fungi; submerged fermentation
Mesh:
Substances:
Year: 2011 PMID: 21339948 PMCID: PMC3039472 DOI: 10.3390/md9010082
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Protocols developed for the optimization of an extraction model for screening hydrophilic fungal metabolites.
Protein and sugar contents of mycelium and medium crude extracts of the six studied marine fungal strains in ASF (agar surface fermentation) obtained by EOP (extraction by organic process) and EAP (extraction by aqueous process) and in SmF (submerged fermentation) obtained by EAP.
| EOP | EAP | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASF | ASF | SmF | ||||||||||
| mycelium | agar-agar | mycelium | agar-agar | mycelium | filtrate | |||||||
| protein yield | sugar yield | protein yield | sugar yield | protein yield | sugar yield | protein yield | sugar yield | protein yield | sugar yield | protein yield | sugar yield | |
| (mg/g dw) | (mg/g dw) | (mg/mL) | (mg/mL) | (mg/g dw) | (mg/g dw) | (mg/mL) | (mg/mL) | (mg/g dw) | (mg/g dw) | (mg/mL) | (mg/mL) | |
| 0.78 | 14.25 | 0.07 | 0.25 | 10.67 | 34.19 | 0.55 | 2.13 | 9.52 | 35.41 | 0.36 | 2.27 | |
| 1.11 | 11.11 | 0.09 | 0.65 | 14.45 | 33.32 | 0.60 | 3.56 | 13.87 | 32.15 | 0.37 | 4.13 | |
| 2.48 | 20.23 | 0.05 | 0.31 | 10.50 | 44.25 | 0.22 | 0.85 | 11.19 | 42.63 | 0.19 | 0.77 | |
| 4.01 | 36.43 | 0.12 | 0.21 | 16.04 | 51.35 | 0.42 | 1.33 | 16.54 | 50.86 | 0.28 | 1.19 | |
| 5.70 | 37.66 | 0.08 | 0.45 | 21.03 | 55.28 | 0.15 | 2.43 | 23.17 | 53.77 | 0.13 | 2.25 | |
| 2.43 | 20.30 | 0.09 | 0.42 | 12.44 | 46.66 | 0.20 | 2.97 | 11.35 | 45.34 | 0.18 | 2.08 | |
expressed per mL of culture medium.
Neuroactivity on Diptera larvae expressed by the MED (minimal effective dose) in mg/mL and cytotoxicity on KB cells expressed by the IC50 (inhibition concentration of 50% of cellular growth) in μg/mL of mycelium and medium crude extracts of the six studied marine fungal strains cultivated in ASF (agar surface fermentation) extracted by EOP (extraction by organic process) and EAP (extraction by aqueous process) and in SmF (submerged fermentation) extracted by EAP.
| EOP | EAP | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASF | ASF | SmF | ||||||||||
| mycelium | agar-agar | mycelium | agar-agar | mycelium | filtrate | |||||||
| neuroactivity | cytotoxicity | neuroactivity | cytotoxicity | neuroactivity | cytotoxicity | neuroactivity | cytotoxicity | neuroactivity | cytotoxicity | neuroactivity | cytotoxicity | |
| MED | IC50 | MED | IC50 | MED | IC50 | MED | IC50 | MED | IC50 | MED | IC50 | |
| mg/mL | μg/mL | mg/mL | μg/mL | mg/mL | μg/mL | mg/mL | μg/mL | mg/mL | μg/mL | mg/mL | μg/mL | |
| 100 | - | 100 | - | 12.5 | - | 100 | - | 50 | - | - | - | |
| 50 | - | - | - | 25 | 68 | 100 | 130 | 50 | 62 | 100 | 85 | |
| 50 | - | 100 | - | - | - | - | 57 | - | - | - | 97 | |
| 100 | - | 100 | - | 100 | - | - | 44 | - | - | - | 48 | |
| 100 | - | 100 | - | 100 | - | - | - | 100 | - | - | - | |
| 100 | - | - | - | - | 70 | - | - | - | 94 | - | - | |
| - | - | - | - | - | - | |||||||
The sign – means the absence of neuroactivity or cytotoxicity at the highest tested concentrations.
Positive control: - neuroactivity: domoic acid; MED = 50 ng/mL; - cytotoxicity: gliotoxin; IC50 = 0.3 μg/mL.
Biomass of the six studied marine fungal strains obtained by ASF (agar surface fermentation) and SmF (submerged fermentation).
Biomass | ||
|---|---|---|
| ASF | SmF | |
| 50.0 ± 2.1 | 35.6 ± 1.8 | |
| 33.3 ± 1.7 | 7.1 ± 0.2 | |
| 53.4 ± 2.4 | 6.2 ± 0.3 | |
| 57.9 ± 2.6 | 2.0 ± 0.1 | |
| 5.8 ± 0.3 | 0.8 ± 0.3 | |
| 54.2 ± 1.9 | 31.7 ± 1.5 | |
expressed per liter of culture medium; results represent biomass mean ± SD (n = 3).
Figure 2Analysis of protein components of EAP extracts from P. citreonigrum strain in ASF (agar surface fermentation) and SmF (submerged fermentation). SDS-PAGE electrophoresis (12% acrylamide) and successive Coomassie blue and silver stainings. M: molecular weight markers (in kDa), Lanes 1: cryo-crushed mycelium from ASF, 2: cryo-crushed mycelium from SmF, 3: digested agar-agar from ASF, 4: inert agar-agar, 5: culture filtrate from SmF, 6: inert culture filtrate.
Figure 3Proposed protocol for the production and extraction of bioactive hydrophilic fungal metabolites.